Pancreatic Cancer Research

ResearcherUniversitat de GironaNo recent work listed

Laura Miró

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7111-1811; OpenAlex author ID A5091706095. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in… Co-author DOI 10.3390/cancers14246133↗
  2. Knockdown of α2,3-Sialyltransferases Impairs Pancreatic Cancer Cell Migration, Invasion and E-selectin-Dependent Adhesion. First author DOI 10.3390/ijms21176239↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Esther Llop · 2 shared papers, 2020–2022 · strength 0.26
  2. Pedro Enrique Guerrero · 2 shared papers, 2020–2022 · strength 0.26
  3. Neus Martínez‐Bosch · 2 shared papers, 2020–2022 · strength 0.26
  4. Pilar Navarro · 2 shared papers, 2020–2022 · strength 0.26
  5. Rosa Peracaula · 2 shared papers, 2020–2022 · strength 0.26
  6. Noemí Manero‐Rupérez · 1 shared paper, 2022 · strength 0.15
  7. Κωνσταντίνος Κωνσταντόπουλος · 1 shared paper, 2020 · strength 0.11
  8. Bin Sheng Wong · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.